We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+3.31%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$1.67T
AUM Growth
+$23.3B
Cap. Flow
-$2.36B
Cap. Flow %
-0.14%
Top 10 Hldgs %
22.15%
Holding
8,587
New
427
Increased
3,948
Reduced
2,961
Closed
384

Sector Composition

Rank Sector Weight
1 Technology 22.44%
2 Financials 11.15%
3 Consumer Discretionary 8.06%
4 Healthcare 8.02%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DCOM icon
3476
Dime Commercial Bancshares
DCOM
$1.8B
$11.4M ﹤0.01%
377,704
+30,095
+9% +$869K
AQST icon
3477
Aquestive Therapeutics
AQST
$472M
$11.4M ﹤0.01%
1,758,750
+348,641
+25% +$2.17M
RCAT icon
3478
Red Cat Holdings
RCAT
$1.13B
$11.4M ﹤0.01%
1,431,953
+477,843
+50% +$4.57M
GTN icon
3479
Gray Television
GTN
$430M
$11.3M ﹤0.01%
2,338,308
+633,532
+37% +$3.1M
KALV
3480
DELISTED
KalVista Pharmaceuticals
KALV
$11.3M ﹤0.01%
700,228
+135,372
+24% +$1.79M
HPS
3481
John Hancock Preferred Income Fund III
HPS
$457M
$11.3M ﹤0.01%
783,453
+2,140
+0.3% +$32.2K
DBD icon
3482
Diebold Nixdorf
DBD
$3.14B
$11.3M ﹤0.01%
166,275
+63,982
+63% +$4M
IBMQ icon
3483
iShares iBonds Dec 2028 Term Muni Bond ETF
IBMQ
$657M
$11.2M ﹤0.01%
438,509
+66,828
+18% +$1.71M
FAX
3484
abrdn Asia-Pacific Income Fund
FAX
$595M
$11.2M ﹤0.01%
730,698
-123,073
-14% -$1.9M
MRVI icon
3485
Maravai LifeSciences
MRVI
$1.01B
$11.2M ﹤0.01%
3,446,802
+563,035
+20% +$1.9M
EMBC icon
3486
Embecta
EMBC
$213M
$11.2M ﹤0.01%
941,564
+37,150
+4% +$490K
TK icon
3487
Teekay
TK
$981M
$11.2M ﹤0.01%
1,237,196
+252,507
+26% +$2.32M
BBH icon
3488
VanEck Biotech ETF
BBH
$409M
$11.2M ﹤0.01%
59,010
+27,350
+86% +$5.06M
KBWY icon
3489
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$321M
$11.2M ﹤0.01%
723,172
-10,681
-1% -$165K
BBSI icon
3490
Barrett Business Services
BBSI
$1.01B
$11.1M ﹤0.01%
307,808
+70,384
+30% +$2.69M
DOLE icon
3491
Dole
DOLE
$1.35B
$11.1M ﹤0.01%
742,987
+248,169
+50% +$3.46M
EZA icon
3492
iShares MSCI South Africa ETF
EZA
$533M
$11.1M ﹤0.01%
160,944
+3,457
+2% +$229K
SAFT icon
3493
Safety Insurance
SAFT
$1.51B
$11.1M ﹤0.01%
142,087
+11,180
+9% +$827K
CODI icon
3494
Compass Diversified
CODI
$777M
$11.1M ﹤0.01%
2,305,229
+1,249,559
+118% +$7.9M
GCMG icon
3495
GCM Grosvenor
GCMG
$745M
$11M ﹤0.01%
975,874
-94,748
-9% -$1.08M
BGS icon
3496
B&G Foods
BGS
$297M
$11M ﹤0.01%
2,568,910
+436,186
+20% +$1.95M
DFAS icon
3497
Dimensional US Small Cap ETF
DFAS
$15.5B
$11M ﹤0.01%
158,429
-74,415
-32% -$5.13M
FOCL
3498
EDAP TMS S.A.
FOCL
$227M
$11M ﹤0.01%
3,352,080
-9,700
-0.3% -$23.3K
BHVN icon
3499
Biohaven
BHVN
$2.07B
$11M ﹤0.01%
975,196
+429,381
+79% +$5.32M
BSMW icon
3500
Invesco BulletShares 2032 Municipal Bond ETF
BSMW
$213M
$11M ﹤0.01%
438,308
+121,273
+38% +$3.05M

Similar funds

Morgan Stanley's Q4 2025 Portfolio in Review

As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Morgan Stanley's Q4 2025 filing shows 427 new, 3,948 increased, 2,961 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
  • Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
  • Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
  • Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
  • Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
  • Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
  • Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.

Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.